ArrePath Revenue and Competitors
Estimated Revenue & Valuation
- ArrePath's estimated annual revenue is currently $1.7M per year.
- ArrePath's estimated revenue per employee is $77,500
Employee Data
- ArrePath has 22 Employees.
- ArrePath grew their employee count by 83% last year.
ArrePath's People
| Name | Title | Email/Phone |
|---|
ArrePath Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is ArrePath?
ArrePath is a biotech company discovering and developing new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies. We apply world-class science and innovation in imaging and AI / ML technologies to identify and develop novel drugs to address global health issues. Our advanced machine learning (ML) and imaging-based drug discovery platform enables a rapid and efficient identification of new drug classes with desired activity profiles and clinical utility, coupled with a deep understanding of mechanism of action at the outset of the discovery process.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$1.7M
Revenue (est)
83%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Princeton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.4M | 22 | -15% | N/A |
#2 | $2.8M | 22 | -19% | N/A |
#3 | $2.6M | 22 | 0% | N/A |
#4 | $2.3M | 23 | -4% | N/A |
#5 | $7.5M | 23 | -8% | $38.7M |